Massimo Breccia

机构：Policlinico Umberto I, Sapienza University of Rome · ORCID：0000-0003-1163-6162

发表论文 1055 篇 · 总被引 17918 次 · h-index 60

代表论文

• Venetoclax and decitabine in myeloproliferative neoplasm-blast Phase (MPN-BP): Results of enable, a gimema and airc-mynerva multicenter, Phase 2 trial (2025 · Blood · 被引 3)
• Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 (2025 · Blood Advances · 被引 2)
• Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint (2025 · Leukemia · 被引 2)
• Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission (2026 · Cancers · 被引 1)
• ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors (2026 · Leukemia · 被引 1)
• Germline heterozygous SH2B3 p.Glu78Lys variant: a three-patient case series with myeloproliferative neoplasms (2025 · Experimental Hematology · 被引 1)